Antitumor activity of pan‐HER inhibitors in HER2‐positive gastric cancer

Molecularly targeted therapy has enabled outstanding advances in cancer treatment. Whereas various anti‐human epidermal growth factor receptor 2 (HER2) drugs have been developed, trastuzumab is still the only anti‐HER2 drug presently available for gastric cancer. In this study, we propose novel trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshioka, Takahiro, Shien, Kazuhiko, Namba, Kei, Torigoe, Hidejiro, Sato, Hiroki, Tomida, Shuta, Yamamoto, Hiromasa, Asano, Hiroaki, Soh, Junichi, Tsukuda, Kazunori, Nagasaka, Takeshi, Fujiwara, Toshiyoshi, Toyooka, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891184/
https://www.ncbi.nlm.nih.gov/pubmed/29465762
http://dx.doi.org/10.1111/cas.13546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891184/
https://www.ncbi.nlm.nih.gov/pubmed/29465762
http://dx.doi.org/10.1111/cas.13546

Ejemplares similares